LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Interleukins Produced in Response to Infection by Parasitic Worms Protect the Body from Autoimmune Attack

By LabMedica International staff writers
Posted on 08 Aug 2012
Print article
A recent paper discussed the molecular basis for the lower incidence of type I diabetes in developing countries caused by intestinal worm infections.

Chronic intestinal worm infections are known to blunt the effect of the self-aggressive T-cells that cause diabetes and other autoimmune diseases. To determine which molecular signals trigger this loss of autoimmune activity investigators at the University of Medicine and Dentistry of New Jersey (Newark, USA) infected nonobese diabetic (NOD) mice with the strictly enteric nematode parasite, Heligmosomoides polygyrus and then evaluated the types of cytokines produced by these animals.

They reported in the July 18, 2012, online edition of the journal Mucosal Immunology that two weeks of infection with H. polygyrus (which was then cured using oral drugs) induced T-cells to produce the cytokines interleukin (IL)-4 and IL-10, which acted independently to block T-cell autoimmune activity and provide lasting protection against development of type I diabetes. Blockade of IL-10 signaling in some mice during this short interval eliminated the protective effects of the worm infection and resulted in pancreatic beta-cell destruction and ultimately type I diabetes.

These results outline potential mechanisms to explain the potency of parasite-induced control of inflammatory diseases. Follow-up clinical studies are using eggs from another parasitic worm, Trichuris suis, to treat patients with Crohn’s disease and multiple sclerosis.

Related Links:
University of Medicine and Dentistry of New Jersey



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more